ICCC - ImmuCell Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue9,543.96110,228.6897,596.874
Cost of Revenue4,123.2663,977.7873,147.837
Gross Profit5,420.6956,250.9024,449.037
Operating Expenses
Research Development1,244.3351,235.3092,179.079
Selling General and Administrative3,286.1562,893.2712,476.356
Non Recurring---
Total Operating Expenses---
Operating Income or Loss890.2042,122.322-206.398
Income from Continuing Operations
Total Other Income/Expenses Net-131.882-58.774-49.053
Earnings Before Interest and Taxes758.3222,063.548-255.451
Interest Expense---
Income Before Tax758.3222,063.548-255.451
Income Tax Expense249.874850.309-88.292
Minority Interest---
Net Income From Continuing Ops508.4481,213.239-167.159
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income508.4481,213.239-167.159
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares508.4481,213.239-167.159